Regulation And Legal
Panacea Biotec Subsidiary Receives ₹4.06 Crore GST Notice
Panacea Biotec's subsidiary PBPL received GST show cause notice alleging ₹4.06 crore tax liability for FY 2022-23.
Notice alleges excess input tax credit claim of ₹2.27 crore tax, ₹1.56 crore interest
